| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 426.16 Million |
| Market Size (2030) | USD 499.10 Million |
| CAGR (2025 - 2030) | 3.21% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
France Nuclear Imaging Market Analysis by Mordor Intelligence
The France Nuclear Imaging Market size is estimated at USD 426.16 million in 2025, and is expected to reach USD 499.10 million by 2030, at a CAGR of 3.21% during the forecast period (2025-2030).
During the COVID-19 pandemic, the nuclear imaging market in France was significantly affected as a result of lockdown and restrictions on non-essential procedures. According to a study titled 'Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study' published in the National Center for Biotechnology Information in June 2021, the total number of nuclear medicine examinations performed in France dropped by 43.4% in the time span of 4 weeks before and after the lockdown. However, after the COVID-19 pandemic, the market is gaining its momentum back. Therefore, it is observed that despite the decrease in utilization of nuclear imaging during the pandemic, the market is believed to witness steady growth in the coming years.
The studied market growth can largely be attributed to factors, such as the increasing prevalence of cancer and cardiac disorders, and technological advancements in nuclear imaging. Morover, according to the United Nations Population Fund's World Population Dashboard's Statistics 2021, in France, there are about 21.1% of people aged 65 years and above. As the older population is most likely to get affected by chronic diseases, the need for devices for monitoring, diagnosis, and treatment is expected to increase over the forecast period. Thereby boosting the growth of the market studied.
Additionally, technological advancements in nuclear imaging are augmenting the growth of the market studied in France. For instance, in May 2022, physicians from Baclesse Cancer Center, France demonstrated that an artificial intelligence (AI) program can enhance image quality in half-count F-18 FDG-PET scans, opening the door to large acquisition time reductions in standard clinical practice. With the findings from various studies, nuclear medicine specialists from France have started implementing advanced technologies in PET/SPECT scans which is expected to contribute to the growth of the market studied.
France Nuclear Imaging Market Trends and Insights
PET Radioisotopes are Expected to Witness Strong Growth in Future
The radioisotopes used in PET to label tracers are 11C, 13N, 150, and 18F (carbon, nitrogen, oxygen, and 18F are used as a substitute for hydrogen). The body will absorb these radioactive forms of natural elements, which the scanner will detect. These isotopes can be used to label a number of substances and medications.
The activities undertaken by key companies operating in the nuclear imaging market are fueling the growth of the segment. For instance, in March 2021, Eckert & Ziegler Radiopharma GmbH and Curium PET France decided to reinforce their existing long-term partnership by extending their agreement for the distribution of Galliapharm generators in France, Curium being the partner of choice given the national coverage of its PET network in France. Additionally, in August 2021, Curium submitted an Investigational New Drug (IND) application for Cu-64 PSMA I&T, a radiopharmaceutical that binds to Prostate-Specific Membrane Antigen (PSMA) for use with Positron Emission Tomography (PET), for the detection and localization of metastatic prostate cancer.
With the increasing involvement of key companies in PET radioisotope segment, it is expected that PET radioisotopes will be witnessing a healthy growth in coming years.
Understand The Key Trends Shaping This Market
Download PDF
Competitive Landscape
The nuclear imaging market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, like Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, among others, hold a substantial share in the market.
France Nuclear Imaging Industry Leaders
-
GE Healthcare
-
Canon Medical Systems
-
Koninklijke Philips N.V.
-
Bracco Imaging Spa
-
Siemens AG
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- In May 2022, Nuclear medicine physicians at the Baclesse Cancer Center in Caen, France developed an Artificial Intelligence algorithm that can be used in PET scanners to improve image quality.
- In January 2021, Koninklijke Philips N.V. and Rennes University Hospital signed a 5-year innovation and technology partnership to support diagnostic, interventional imaging, patient monitoring, and management among other things.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
France Nuclear Imaging Market Report Scope
As per the scope of this report, nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. France Nuclear Imaging market is segmented by Product (Equipment, Diagnostic Radioisotope), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments.
By Product
| Equipment | |
| Diagnostic Radioisotope | SPECT Radioisotopes |
| PET Radioisotopes |
By Application
| SPECT Applications | Cardiology |
| Neurology | |
| Thyroid | |
| Other SPECT Applications | |
| PET Applications | Oncology |
| Cardiology | |
| Neurology | |
| Other PET Applications |
| By Product | Equipment | |
| Diagnostic Radioisotope | SPECT Radioisotopes | |
| PET Radioisotopes | ||
| By Application | SPECT Applications | Cardiology |
| Neurology | ||
| Thyroid | ||
| Other SPECT Applications | ||
| PET Applications | Oncology | |
| Cardiology | ||
| Neurology | ||
| Other PET Applications | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the France Nuclear Imaging Market?
The France Nuclear Imaging Market size is expected to reach USD 426.16 million in 2025 and grow at a CAGR of 3.21% to reach USD 499.10 million by 2030.
What is the current France Nuclear Imaging Market size?
In 2025, the France Nuclear Imaging Market size is expected to reach USD 426.16 million.
Who are the key players in France Nuclear Imaging Market?
GE Healthcare, Canon Medical Systems, Koninklijke Philips N.V., Bracco Imaging Spa and Siemens AG are the major companies operating in the France Nuclear Imaging Market.
What years does this France Nuclear Imaging Market cover, and what was the market size in 2024?
In 2024, the France Nuclear Imaging Market size was estimated at USD 412.48 million. The report covers the France Nuclear Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the France Nuclear Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
France Nuclear Imaging Market Report
Statistics for the 2025 France Nuclear Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Nuclear Imaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
